Join us for this interactive symposium on addressing health disparities in anemia of CKD while focusing on current and emerging treatment options. You will gain insights from pharmacy experts on the latest clinical data for the treatment of anemia of CKD and review strategies to identify and address health disparities to provide optimal care to each patient.
Pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with anemia of CKD, as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice
University of Pittsburgh Medical Center Mercy Hospital
Special and Scientific Staff
Tufts Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Patient-Centered, Equitable Care in Anemia of CKD: Minimizing Disease Burden and Health Disparities
There are no fees required to participate in this activity.
Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact email@example.com prior to the live event.
Anemia of CKD is often underdiagnosed and undertreated, especially in patients with health disparities, which leads to significant morbidity and mortality. This educational activity will review the current and emerging treatment options for anemia of CKD and strategies to minimize healthcare disparities in these patients.
The goal of this program is to improve the knowledge and competence of learners about current and emerging treatment options for anemia of CKD and strategies to minimize healthcare disparities in the management of patients with anemia and CKD.
This activity is intended for pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with anemia of CKD, as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.
Upon completion of this activity, participants should be able to:
ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-23-005-L01-P has been assigned to this live application-based activity (initial release date 03/21/2023). This activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
ProCE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Provided by ProCE, LLC
This educational activity is supported by an educational grant from GlaxoSmithKline.